Product Images Topiramate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 8 images provide visual information about the product associated with Topiramate NDC 68462-153 by Glenmark Pharmaceuticals Inc., Usa, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure1
The text represents a graph showing the cumulative rates for time to the first seizure for two different doses of topiramate (50mg/day and 400mg/day) over a period of 300 days. The graph shows the percentage of patients who have not experienced a seizure at a given time point.*
Figure2
The text describes a table showing the change in the average monthly migraine period rate from baseline to the double-blind phase for different dosages of Topiramate and Placebo. The table shows the sample size for each group and specifies the study number. The text also includes asterisks indicating statistical significance levels.*
LBL100mg60
LBL200mg60
LBL25mg60
LBL50mg60
Logo
Structure
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.